MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on Blue MedicareRx Essentials (S5726-020)

Epclusa, Mavyret, Harvoni and their generics, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Kansas
Premium
$0.00/month
Deductible
$615.00, doesn't apply to tier 1 and 2
Change plan

2 of 6 Hepatitis C drugs are covered on this plan. All 2 require prior authorization.

4 aren't on the formulary, including Epclusa and sofosbuvir-velpatasvir.

  • Mavyret
    glecaprevir and pibrentasvir
    Covered · prior auth
    25%
    Tier 5
  • Vosevi
    sofosbuvir
    Covered · prior auth
    25%
    Tier 5
Not on the formulary
Epclusa, sofosbuvir-velpatasvir, Harvoni, ledipasvir-sofosbuvir

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list